Accustem Sciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch ACUT and buy or sell other stocks, ETFs, and their options commission-free!

About ACUT

AccuStem Sciences, Inc. is a clinical stage diagnostics company, which engages in medical practice activities. It also focuses on commercialization of a proprietary genomic test, StemPrintER, for patients with early-stage breast cancer. 

CEO
Wendy Blosser
CEOWendy Blosser
Employees
2
Employees2
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2020
Founded2020
Employees
2
Employees2

ACUT Key Statistics

Market cap
30.70M
Market cap30.70M
Price-Earnings ratio
-15.88
Price-Earnings ratio-15.88
Dividend yield
Dividend yield
Average volume
2.15K
Average volume2.15K
High today
$1.98
High today$1.98
Low today
$1.69
Low today$1.69
Open price
$1.98
Open price$1.98
Volume
196.00
Volume196.00
52 Week high
$2.33
52 Week high$2.33
52 Week low
$0.2159
52 Week low$0.2159
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.